The differences in prognostic factors between pathological stage I invasive squamous cell carcinoma and adenocarcinoma of the lung.
Not Applicable
- Conditions
- pathological stage I invasive squamous cell carcinoma and adenocarcinoma of the lung.
- Registration Number
- JPRN-UMIN000013367
- Lead Sponsor
- Division of General Thoracic Surgery, Department of Surgery, Keio University School of Medicine, Tokyo, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who had received preoperative chemotherapy or thoracic radiotherapy were excluded. We also excluded patients with Ad which was pathologically proven as a pre-invasive lesion such as atypical adenomatous hyperplasia and lung adenocarcinoma in situ.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall survival, recurrence free survival
- Secondary Outcome Measures
Name Time Method